South Korea Infectious Diagnostics Market Outlook to 2024

Published : Nov-2017

No. of Pages : 141

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Infectious Diagnostics Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 11
3 Infectious Diagnostics Market, South Korea 16
3.1 Infectious Diagnostics Market, South Korea, Revenue ($m), 2010-2017 16
3.2 Infectious Diagnostics Market, South Korea, Revenue ($m), 2017-2024 19
3.2.1 Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Revenue ($m), by Segment, 2010-2017 22
3.2.2 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Revenue ($m), by Segment, 2010-2017 24
3.2.3 Hepatitis Test Kits Market, South Korea, Revenue ($m), by Segment, 2010-2017 26
3.2.4 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, South Korea, Revenue ($m), by Segment, 2010-2017 28
3.2.5 Infectious Diagnostics Multiple Parameter Test Kits Market, South Korea, Revenue ($m), by Segment, 2010-2017 30
3.2.6 Infectious Diagnostics Rapid Tests & POC Market, South Korea, Revenue ($m), by Segment, 2010-2017 32
3.2.7 Mycobacterium tuberculosis Diagnostic Tests Market, South Korea, Revenue ($m), by Segment, 2010-2017 34
3.2.8 Polymerase Chain Reaction (PCR) Systems Market, South Korea, Revenue ($m), by Segment, 2010-2017 36
3.2.9 Post Streptococcus pyogenes Diagnostic Tests Market, South Korea, Revenue ($m), by Segment, 2010-2017 38
3.2.10 Retrovirus Tests Market, South Korea, Revenue ($m), by Segment, 2010-2017 40
3.2.11 Treponema pallidum Diagnostic Tests Market, South Korea, Revenue ($m), by Segment, 2010-2017 42
3.2.12 Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Revenue ($m), by Segment, 2017-2024 44
3.2.13 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Revenue ($m), by Segment, 2017-2024 46
3.2.14 Hepatitis Test Kits Market, South Korea, Revenue ($m), by Segment, 2017-2024 48
3.2.15 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, South Korea, Revenue ($m), by Segment, 2017-2024 50
3.2.16 Infectious Diagnostics Multiple Parameter Test Kits Market, South Korea, Revenue ($m), by Segment, 2017-2024 52
3.2.17 Infectious Diagnostics Rapid Tests & POC Market, South Korea, Revenue ($m), by Segment, 2017-2024 54
3.2.18 Mycobacterium tuberculosis Diagnostic Tests Market, South Korea, Revenue ($m), by Segment, 2017-2024 56
3.2.19 Polymerase Chain Reaction (PCR) Systems Market, South Korea, Revenue ($m), by Segment, 2017-2024 58
3.2.20 Post Streptococcus pyogenes Diagnostic Tests Market, South Korea, Revenue ($m), by Segment, 2017-2024 60
3.2.21 Retrovirus Tests Market, South Korea, Revenue ($m), by Segment, 2017-2024 62
3.2.22 Treponema pallidum Diagnostic Tests Market, South Korea, Revenue ($m), by Segment, 2017-2024 64
3.3 Infectious Diagnostics Market, South Korea, Volume (Units), 2010-2017 66
3.4 Infectious Diagnostics Market, South Korea, Volume (Units), 2017-2024 69
3.4.1 Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Volume (Units), by Segment, 2010-2017 72
3.4.2 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Volume (Units), by Segment, 2010-2017 74
3.4.3 Hepatitis Test Kits Market, South Korea, Volume (Units), by Segment, 2010-2017 76
3.4.4 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, South Korea, Volume (Units), by Segment, 2010-2017 78
3.4.5 Infectious Diagnostics Multiple Parameter Test Kits Market, South Korea, Volume (Units), by Segment, 2010-2017 80
3.4.6 Infectious Diagnostics Rapid Tests & POC Market, South Korea, Volume (Units), by Segment, 2010-2017 82
3.4.7 Mycobacterium tuberculosis Diagnostic Tests Market, South Korea, Volume (Units), by Segment, 2010-2017 84
3.4.8 Polymerase Chain Reaction (PCR) Systems Market, South Korea, Volume (Units), by Segment, 2010-2017 86
3.4.9 Post Streptococcus pyogenes Diagnostic Tests Market, South Korea, Volume (Units), by Segment, 2010-2017 88
3.4.10 Retrovirus Tests Market, South Korea, Volume (Units), by Segment, 2010-2017 90
3.4.11 Treponema pallidum Diagnostic Tests Market, South Korea, Volume (Units), by Segment, 2010-2017 92
3.4.12 Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Volume (Units), by Segment, 2017-2024 94
3.4.13 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Volume (Units), by Segment, 2017-2024 96
3.4.14 Hepatitis Test Kits Market, South Korea, Volume (Units), by Segment, 2017-2024 98
3.4.15 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, South Korea, Volume (Units), by Segment, 2017-2024 100
3.4.16 Infectious Diagnostics Multiple Parameter Test Kits Market, South Korea, Volume (Units), by Segment, 2017-2024 102
3.4.17 Infectious Diagnostics Rapid Tests & POC Market, South Korea, Volume (Units), by Segment, 2017-2024 104
3.4.18 Mycobacterium tuberculosis Diagnostic Tests Market, South Korea, Volume (Units), by Segment, 2017-2024 106
3.4.19 Polymerase Chain Reaction (PCR) Systems Market, South Korea, Volume (Units), by Segment, 2017-2024 108
3.4.20 Post Streptococcus pyogenes Diagnostic Tests Market, South Korea, Volume (Units), by Segment, 2017-2024 110
3.4.21 Retrovirus Tests Market, South Korea, Volume (Units), by Segment, 2017-2024 112
3.4.22 Treponema pallidum Diagnostic Tests Market, South Korea, Volume (Units), by Segment, 2017-2024 114
3.5 Infectious Diagnostics Market, South Korea, Average Price ($), 2010-2024 116
3.6 Infectious Diagnostics Market, South Korea, Distribution Share by Revenue ($m), 2017 122
3.7 Infectious Diagnostics Market, South Korea, Company Share by Revenue ($m), 2017 123
4 Overview of Key Companies in South Korea, Infectious Diagnostics Market 125
4.1 Abbott Laboratories 125
4.1.1 Company Overview 125
4.2 Alere Inc 125
4.2.1 Company Overview 125
4.3 Cepheid 125
4.3.1 Company Overview 125
4.4 F. Hoffmann-La Roche Ltd 125
4.4.1 Company Overview 125
4.5 Qiagen NV 126
4.5.1 Company Overview 126
4.6 Hologic Inc 126
4.6.1 Company Overview 126
4.7 bioMerieux SA 126
4.7.1 Company Overview 126
4.8 Bio-Rad Laboratories Inc 126
4.8.1 Company Overview 126
4.9 Siemens Healthcare GmbH 127
4.9.1 Company Overview 127
4.10 Beckman Coulter Inc 127
4.10.1 Company Overview 127
4.11 Becton Dickinson and Co 127
4.11.1 Company Overview 127
5 Infectious Diagnostics Market Pipeline Products 128
6 Financial Deals Landscape 132
6.1 Partnerships 132
6.1.1 iBio Enters into Agreement with TheoremDx 132
6.1.2 Seegene Enters into Agreement with Thermo Fisher Scientific 133
6.1.3 Stellar Biotech Terminates Licensing Agreement with University of Guelph 134
7 Appendix 135
7.1 Research Methodology 136
7.1.1 Coverage 136
7.1.2 Secondary Research 136
7.1.3 Primary Research 137
7.1.4 Market Modeling and Forecasting 138
7.1.5 Company Share Analysis 139
7.1.6 Distribution Share Analysis 140
7.1.7 Benchmarking 140
7.2 GlobalData Consulting 140
7.3 Contact Us 141
7.4 Disclaimer 141

1.1 List of Tables
Table 1: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 17
Table 2: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 20
Table 3: Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 23
Table 4: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 25
Table 5: Hepatitis Test Kits Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 27
Table 6: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 29
Table 7: Infectious Diagnostics Multiple Parameter Test Kits Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 31
Table 8: Infectious Diagnostics Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 33
Table 9: Mycobacterium tuberculosis Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 35
Table 10: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 37
Table 11: Post Streptococcus pyogenes Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 39
Table 12: Retrovirus Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 41
Table 13: Treponema pallidum Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 43
Table 14: Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 45
Table 15: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 47
Table 16: Hepatitis Test Kits Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 49
Table 17: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 51
Table 18: Infectious Diagnostics Multiple Parameter Test Kits Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 53
Table 19: Infectious Diagnostics Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 55
Table 20: Mycobacterium tuberculosis Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 57
Table 21: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 59
Table 22: Post Streptococcus pyogenes Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 61
Table 23: Retrovirus Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 63
Table 24: Treponema pallidum Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 65
Table 25: Infectious Diagnostics Market, South Korea, Volume (Units), Historic, 2010-2017 67
Table 26: Infectious Diagnostics Market, South Korea, Volume (Units), Forecast, 2017-2024 70
Table 27: Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Volume (Units), Historic, 2010-2017 73
Table 28: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Volume (Units), Historic, 2010-2017 75
Table 29: Hepatitis Test Kits Market, South Korea, Volume (Units), Historic, 2010-2017 77
Table 30: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, South Korea, Volume (Units), Historic, 2010-2017 79
Table 31: Infectious Diagnostics Multiple Parameter Test Kits Market, South Korea, Volume (Units), Historic, 2010-2017 81
Table 32: Infectious Diagnostics Rapid Tests & POC Market, South Korea, Volume (Units), Historic, 2010-2017 83
Table 33: Mycobacterium tuberculosis Diagnostic Tests Market, South Korea, Volume (Units), Historic, 2010-2017 85
Table 34: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Volume (Units), Historic, 2010-2017 87
Table 35: Post Streptococcus pyogenes Diagnostic Tests Market, South Korea, Volume (Units), Historic, 2010-2017 89
Table 36: Retrovirus Tests Market, South Korea, Volume (Units), Historic, 2010-2017 91
Table 37: Treponema pallidum Diagnostic Tests Market, South Korea, Volume (Units), Historic, 2010-2017 93
Table 38: Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Volume (Units), Forecast, 2017-2024 95
Table 39: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 97
Table 40: Hepatitis Test Kits Market, South Korea, Volume (Units), Forecast, 2017-2024 99
Table 41: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 101
Table 42: Infectious Diagnostics Multiple Parameter Test Kits Market, South Korea, Volume (Units), Forecast, 2017-2024 103
Table 43: Infectious Diagnostics Rapid Tests & POC Market, South Korea, Volume (Units), Forecast, 2017-2024 105
Table 44: Mycobacterium tuberculosis Diagnostic Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 107
Table 45: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Volume (Units), Forecast, 2017-2024 109
Table 46: Post Streptococcus pyogenes Diagnostic Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 111
Table 47: Retrovirus Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 113
Table 48: Treponema pallidum Diagnostic Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 115
Table 49: Infectious Diagnostics Market, South Korea, Average Price ($) Historic, 2010-2017 116
Table 50: Infectious Diagnostics Market, South Korea, Average Price ($), Forecast, 2017-2024 119
Table 51: Infectious Diagnostics Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2017 122
Table 52: Infectious Diagnostics Market, South Korea, Company Share by Revenue ($m), USD Constant, 2017 124
Table 53: Infectious Diagnostics Market Pipeline Products 128
Table 54: iBio Enters into Agreement with TheoremDx 132
Table 55: Seegene Enters into Agreement with Thermo Fisher Scientific 133
Table 56: Stellar Biotech Terminates Licensing Agreement with University of Guelph 134
Table 57: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 138

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 16
Figure 2: Infectious Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 19
Figure 3: Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 22
Figure 4: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 24
Figure 5: Hepatitis Test Kits Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 26
Figure 6: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 28
Figure 7: Infectious Diagnostics Multiple Parameter Test Kits Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 30
Figure 8: Infectious Diagnostics Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 32
Figure 9: Mycobacterium tuberculosis Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 34
Figure 10: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 36
Figure 11: Post Streptococcus pyogenes Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 38
Figure 12: Retrovirus Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 40
Figure 13: Treponema pallidum Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Historic, 2010-2017 42
Figure 14: Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 44
Figure 15: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 46
Figure 16: Hepatitis Test Kits Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 48
Figure 17: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 50
Figure 18: Infectious Diagnostics Multiple Parameter Test Kits Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 52
Figure 19: Infectious Diagnostics Rapid Tests & POC Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 54
Figure 20: Mycobacterium tuberculosis Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 56
Figure 21: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 58
Figure 22: Post Streptococcus pyogenes Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 60
Figure 23: Retrovirus Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 62
Figure 24: Treponema pallidum Diagnostic Tests Market, South Korea, Revenue ($m), USD Constant, Forecast, 2017-2024 64
Figure 25: Infectious Diagnostics Market, South Korea, Volume (Units), Historic, 2010-2017 66
Figure 26: Infectious Diagnostics Market, South Korea, Volume (Units), Forecast, 2017-2024 69
Figure 27: Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Volume (Units), Historic, 2010-2017 72
Figure 28: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Volume (Units), Historic, 2010-2017 74
Figure 29: Hepatitis Test Kits Market, South Korea, Volume (Units), Historic, 2010-2017 76
Figure 30: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, South Korea, Volume (Units), Historic, 2010-2017 78
Figure 31: Infectious Diagnostics Multiple Parameter Test Kits Market, South Korea, Volume (Units), Historic, 2010-2017 80
Figure 32: Infectious Diagnostics Rapid Tests & POC Market, South Korea, Volume (Units), Historic, 2010-2017 82
Figure 33: Mycobacterium tuberculosis Diagnostic Tests Market, South Korea, Volume (Units), Historic, 2010-2017 84
Figure 34: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Volume (Units), Historic, 2010-2017 86
Figure 35: Post Streptococcus pyogenes Diagnostic Tests Market, South Korea, Volume (Units), Historic, 2010-2017 88
Figure 36: Retrovirus Tests Market, South Korea, Volume (Units), Historic, 2010-2017 90
Figure 37: Treponema pallidum Diagnostic Tests Market, South Korea, Volume (Units), Historic, 2010-2017 92
Figure 38: Chlamydia trichomatis Diagnostic Test Kits Market, South Korea, Volume (Units), Forecast, 2017-2024 94
Figure 39: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 96
Figure 40: Hepatitis Test Kits Market, South Korea, Volume (Units), Forecast, 2017-2024 98
Figure 41: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 100
Figure 42: Infectious Diagnostics Multiple Parameter Test Kits Market, South Korea, Volume (Units), Forecast, 2017-2024 102
Figure 43: Infectious Diagnostics Rapid Tests & POC Market, South Korea, Volume (Units), Forecast, 2017-2024 104
Figure 44: Mycobacterium tuberculosis Diagnostic Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 106
Figure 45: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Volume (Units), Forecast, 2017-2024 108
Figure 46: Post Streptococcus pyogenes Diagnostic Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 110
Figure 47: Retrovirus Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 112
Figure 48: Treponema pallidum Diagnostic Tests Market, South Korea, Volume (Units), Forecast, 2017-2024 114
Figure 49: Infectious Diagnostics Market, South Korea, Company Share (%) 2017 123

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Hematology Analyzers (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Hematology Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Hematology Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The market for automated Hematology Analyzers is increasing due to their reliability, advanced quality and fast testing mechanisms. The Hematology Analyzer market also benefits from rises in the prevalence of anaemia, increased incidence of blood related diseases and disorders, and the growing importance of blood cell counts in routine diagnostic procedures for patient treatment and monitoring. In developed and developing countries, hematology analyzers are installed in both hospital and reference laboratory set......	$7500

South Korea Infectious Diagnostics Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Hematology Analyzers (In Vitro Diagnostics) – Global Market Analysis and Forecast Model